Built from scratch over a period of three years, this unit fits "in the strategy of expanding the group's pharmacy network, which comes to fill a shortfall in the supply of drugs in this region of the country, as well as providing an international quality service for citizens and employees of companies that operate there", says a statement sent to VerAngola.
Sílvio Samuel, chairman of Grupo Silisa, highlighted that the Quibala unit increases the group's pharmacies to a total of five, two in Luanda, one in Cuanza-Norte province, one in Zaire province and the most recent in Kwanza Sul. "We decided to invest outside Luanda as part of the diversification of the country's economy, and also to offer a quality service to citizens who need it," said the manager.
In this first phase, the new unit has a volume of drugs valued at 20 million kwanzas and guarantees 12 direct and indirect jobs. "We are living in a delicate phase of our economy, but we cannot lower our arms in the face of a situation that requires a
conjugation of efforts so that we can wisely apply the management of the few resources we currently have and help our executive", adds Sílvio Samuel.
The official said that the group currently manages a turnover estimated at more than two billion kwanzas and plans to open two more pharmacies outside Luanda in the next two years. "We have the ambition to become one of the largest pharmacy chains in the country, taking into account the demand and scarcity of drugs in the national market", he concluded.
The Silisa group, a company incorporated under Angolan law, has been in the market for over ten years and operates in the civil construction, pharmaceutical and hotel sectors.
